• hero-img
    IBPS 2025 Breast Cancer

    Pathology Conference 2025
    18-19 January 2025 | Cleveland Clinic Abu Dhabi

    On behalf of the organizing committee, it is with great pleasure that we welcome you to the 2025 Breast Pathology Conference, taking place at Cleveland clinic Abu Dhabi. We are thrilled to have you join us for this vital gathering, where experts from around the world come together to share their knowledge, insights, and advancements in the field of breast pathology. This event is dedicated to advancing our understanding of breast pathology and enhancing the collaboration among professionals in the field.

    We are excited to bring together leading experts, researchers, and practitioners who will share their insights, latest research findings, and clinical practices. Throughout the conference, you will have the opportunity to participate in keynote sessions, panel discussions, and interactive sessions that cover a wide spectrum of topics, including but not limited to, diagnostic advancements, molecular pathology, and emerging therapeutic strategies in breast disease.

    This year’s conference theme, “global perspectives on breast cancer pathology,” reflects our commitment to not only disseminate knowledge but also to foster innovative collaborations that can pave the way for improved patient outcomes. We encourage all participants to engage actively, share your thoughts, and connect with one another.

    • Calendar
      18-19 January 2025
    • Location
      Cleveland Clinic Abu Dhabi
    • Accredited
      CME Accredited

      Conference Learning Objectives

      Review the diagnostic criteria, differential diagnosis, and management implications of various challenging entities in breast pathology.

      Learn about HER2-low breast carcinoma and discuss practical tips for evaluating HER2 IHC at the lower end of the spectrum.

      Enhance diagnostic skills in the interpretation of breast core biopsy specimens.

      Understand the applications of diagnostic, prognostic and predictive IHC markers in breast pathology, with emphasis on the interpretation, reporting and possible pitfalls.

      Discuss the diagnostic features of papillary lesions of the breast, emphasize the importance of clinical and radiologic correlation, and appropriate clinical management for these lesions.

      Key Topics

      • Papillary lesions of the breast
      • It is Fibroepithelial neolplasms and not Fibroepithelial neolplamss
      • Neuroendocrine neoplasms of the breast
      • Her2-low breast carcinoma
      • Digital pathology
      • Diagnostic, predictive and prognostic markers in breast pathology
      • Handling and reporting of post-neoadjuvant chemotherapy specimens

      For further information on sponsorship and exhibition please direct your queries to: Obed Khan MCI Middle East – Dubai Office